pain and disability have been carefully excluded. This is one of the largest materials among validation studies of FIQ published in any language.
All items were linked to the International Classification of Functioning, Disability and Health. The results were compared with six pain-related assessment protocols available in Finnish, two of them validated previously in Finnish, plus the patients own estimate of their general well-being. Good correlation was observed between the Finn-FIQ and the Rand-36 item health survey, the Health Assessment Questionnaire or the patients' self-assessment of general well-being. Results of Finn-FIQ were stable when repeated after six months both for newly diagnosed cases and those of longer duration (>2 years).
Undoubtedly, Finn-FIQ, being now validated as a multidimensional assessment tool and showing exceptionally high response rate among patients, will find extensive use both among Finnish doctors treating fibromyalgia patients and those studying fibromyalgia in Finnish-speaking population. Added value of specific language-based validation for non-Finnish-speaking pain doctors may arise from the authors' critical reconsideration of the original version, in which they point out variance in the response rate of some sub-items. In addition, some fine-tuning of the original questionnaire was made, based on obvious gaps in the previous versions validated in other languages.
We are looking forward to further studies showing the sensitivity of Finn-FIQ to detect changes caused by treatment interventions.
